Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Iborra

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|April 10, 2009
[Prognostic factors in renal cell carcinoma]N Letang, L Cabaniols, D Pouessel, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2022
[Adhesion of urologists to the recommendations of the French Urological Association Cancer Committee (CCAFU) in the imaging work-up of localized prostate cancer]B Trétarre, S-G Trouche-Sabatier, A-S Foucan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 30, 2009
[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault]J Jegu, B Tretarre, P Grosclaude, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 30, 2023
[Bladder tumors in the Hérault department: Results of the Hérault tumor registry registration from1987 to 2019]E Bruneaux, F Iborra, S G Trouche-Sabatier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2014
[CCAFU Recommendations 2013: Testicular germ cell cancer]X Durand, J Rigaud, C Avancès, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2014
[CCAFU Recommendations 2013: Penile cancer]J Rigaud, C Avancès, P Camparo, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 8, 2020
[Renal cell carcinoma in the department of Hérault: Results over a 30 year period]M Hutin, B Trétarre, C Gras, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 22, 2020
Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC)A Villers, F Bessaoud, B Trétarre, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 17, 2021
[Cancers of the external genital organs of male in Hérault: Results from the Hérault tumor register (RTH) over a period of 30 years (1987-2016)]M Zarka, B Tretarre, X Rebillard, et al.
The Journal of Urology|January 21, 2020
Malignancy after Augmentation Enterocystoplasty: A Nationwide Study of Natural History, Prognosis and Oncogene Panel AnalysisS Garnier, J Vendrell, B Boillot, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|April 10, 2009
[Prognostic factors in renal cell carcinoma]N Letang, L Cabaniols, D Pouessel, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2022
[Adhesion of urologists to the recommendations of the French Urological Association Cancer Committee (CCAFU) in the imaging work-up of localized prostate cancer]B Trétarre, S-G Trouche-Sabatier, A-S Foucan, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 30, 2009
[Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault]J Jegu, B Tretarre, P Grosclaude, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 30, 2023
[Bladder tumors in the Hérault department: Results of the Hérault tumor registry registration from1987 to 2019]E Bruneaux, F Iborra, S G Trouche-Sabatier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2014
[CCAFU Recommendations 2013: Testicular germ cell cancer]X Durand, J Rigaud, C Avancès, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2014
[CCAFU Recommendations 2013: Penile cancer]J Rigaud, C Avancès, P Camparo, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 8, 2020
[Renal cell carcinoma in the department of Hérault: Results over a 30 year period]M Hutin, B Trétarre, C Gras, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 22, 2020
Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC)A Villers, F Bessaoud, B Trétarre, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 17, 2021
[Cancers of the external genital organs of male in Hérault: Results from the Hérault tumor register (RTH) over a period of 30 years (1987-2016)]M Zarka, B Tretarre, X Rebillard, et al.
The Journal of Urology|January 21, 2020
Malignancy after Augmentation Enterocystoplasty: A Nationwide Study of Natural History, Prognosis and Oncogene Panel AnalysisS Garnier, J Vendrell, B Boillot, et al.
Pageof 6